Ginkgo Bioworks Holdings Inc. (DNA)$8.41
Market Cap: 402.39 MCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Ginkgo Bioworks Holdings Inc. (DNA).
HEALTHCARE
BIOTECHNOLOGY
DCF ready
Valuation
-1.3x
EV/FCF, N/A FCF yield
Quality
-0.1%
ROIC, -105.0% FCF margin
Growth
17.3%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 4.9x current ratio
Superinvestors
1
Top: Viking Global Investors (0.1%)
Strengths to research
- Revenue compounded at 17.3% over five years.
- Debt/equity looks manageable at 0.0x.
Watchouts
- Free cash flow margin is negative at -105.0%.
Annual data: 7 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for DNA.
Grade F
22
/ 100
Peer Comparison
Target stock against 8 market-cap comparable peers.
Heat map: red worst to green best
| DNA Target | Ginkgo Bioworks Holdings Inc. | $402.4M | -1.5x | -1.3x | -0.1% | 17.3% | -105.0% | N/A | N/A | N/A |
| ORIC | ORIC Pharmaceuticals Inc. | $405.2M | -5.7x | -3.2x | -33.7% | N/A | N/A | N/A | N/A | N/A |
| PGEN | Precigen Inc. | $448.7M | -3.1x | -5.7x | -219.7% | -21.3% | -927.6% | N/A | N/A | N/A |
| TRVI | Trevi Therapeutics Inc. | $667.1M | -44.2x | -15.4x | -23.3% | N/A | N/A | N/A | N/A | N/A |
| NUVB | Nuvation Bio Inc. | $808.4M | -7.9x | -4.0x | -58.0% | N/A | -275.7% | N/A | N/A | N/A |
| RCKT | Rocket Pharmaceuticals Inc. | $838.3M | -1.5x | -4.0x | -80.5% | N/A | N/A | N/A | N/A | N/A |
| INBX | Inhibrx | $178.5M | -11.2x | -0.4x | -1752.2% | N/A | -9986.5% | N/A | N/A | N/A |
| DMAC | DiaMedica Therapeutics Inc. | $171.4M | N/A | -5.4x | -58.4% | N/A | N/A | N/A | N/A | N/A |
| PHVS | Pharvaris NV | $1.0B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Financial Charts
No financial data available for DNA (annual).
1 superinvestors own DNA
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Viking Global Investors Viking Global Investors | 3,577,128 | $22M | 0.06% | 0.0% |